Ethic Inc’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.25M | Buy |
49,205
+1,753
| +4% | +$151K | 0.08% | 270 |
|
|
2025
Q1 | $3.19M | Buy |
47,452
+6,294
| +15% | +$424K | 0.06% | 309 |
|
|
2024
Q4 | $3.2M | Buy |
41,158
+5,123
| +14% | +$398K | 0.06% | 302 |
|
|
2024
Q3 | $5M | Sell |
36,035
-1,775
| -5% | -$246K | 0.13% | 194 |
|
|
2024
Q2 | $4.29M | Buy |
37,810
+1,775
| +5% | +$201K | 0.1% | 221 |
|
|
2024
Q1 | $5M | Buy |
36,035
+3,017
| +9% | +$418K | 0.13% | 194 |
|
|
2023
Q4 | $4.1M | Buy |
33,018
+2,026
| +7% | +$251K | 0.12% | 201 |
|
|
2023
Q3 | $2.89M | Sell |
30,992
-1,580
| -5% | -$147K | 0.1% | 245 |
|
|
2023
Q2 | $4.19M | Buy |
32,572
+4,766
| +17% | +$612K | 0.16% | 159 |
|
|
2023
Q1 | $3.23M | Buy |
27,806
+1,534
| +6% | +$178K | 0.13% | 200 |
|
|
2022
Q4 | $2.98M | Sell |
26,272
-1,672
| -6% | -$189K | 0.16% | 171 |
|
|
2022
Q3 | $2.25M | Buy |
27,944
+3,155
| +13% | +$254K | 0.15% | 169 |
|
|
2022
Q2 | $1.85M | Buy |
24,789
+2,721
| +12% | +$203K | 0.13% | 210 |
|
|
2022
Q1 | $2.82M | Buy |
22,068
+6,700
| +44% | +$857K | 0.19% | 128 |
|
|
2021
Q4 | $2.06M | Buy |
15,368
+11,036
| +255% | +$1.48M | 0.16% | 157 |
|
|
2021
Q3 | $592K | Buy |
+4,332
| New | +$592K | 0.06% | 328 |
|